Trial intelligence / Profile preview

Propofol TCI combined with etomidate for painless gastrointestinal endoscopy

ChiCTR2100044708Phase 4Completed

Sponsor
Fujian Medical University Union Hospital
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of propofol and etomidate in gastrointestinal conditions (3 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: Blood pressure, Heart rate and 4 more. Started Aug 2018; status: completed.

02

Drugs

propofoletomidate
03

Conditions

gastrointestinal conditions

Beyond the preview

Go deeper on ChiCTR2100044708.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044708.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call